CRIS Current Research Information System

FARABEGOLI, FULVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.795
AS - Asia 1.553
EU - Europa 1.451
AF - Africa 131
SA - Sud America 111
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.761
CN - Cina 538
IT - Italia 527
SG - Singapore 499
GB - Regno Unito 233
DE - Germania 132
VN - Vietnam 124
SE - Svezia 119
HK - Hong Kong 114
IN - India 94
BR - Brasile 82
CH - Svizzera 80
KR - Corea 79
RU - Federazione Russa 59
FR - Francia 57
IE - Irlanda 52
NL - Olanda 47
CI - Costa d'Avorio 41
TG - Togo 40
UA - Ucraina 29
CA - Canada 23
JP - Giappone 23
NG - Nigeria 21
FI - Finlandia 20
EE - Estonia 18
BG - Bulgaria 17
ZA - Sudafrica 17
ID - Indonesia 15
TR - Turchia 12
AR - Argentina 11
IR - Iran 11
GR - Grecia 10
JO - Giordania 10
AT - Austria 9
ES - Italia 9
MX - Messico 9
TW - Taiwan 9
PL - Polonia 7
BE - Belgio 6
AU - Australia 5
BD - Bangladesh 5
CL - Cile 5
PT - Portogallo 5
DK - Danimarca 4
EC - Ecuador 4
DZ - Algeria 3
LT - Lituania 3
MA - Marocco 3
PY - Paraguay 3
RO - Romania 3
SC - Seychelles 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
KZ - Kazakistan 2
PH - Filippine 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SI - Slovenia 1
SM - San Marino 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 5.047
Salva come PNG Salva come JPEG
Città #
Singapore 343
Ashburn 227
Hefei 193
Southend 185
Bologna 183
Chandler 177
Fairfield 156
Hong Kong 107
Santa Clara 96
Woodbridge 85
Seattle 83
Bern 75
Seoul 74
Wilmington 72
Houston 71
Beijing 59
Cambridge 55
Dublin 50
Princeton 49
Abidjan 41
Lomé 40
Milan 38
Dallas 37
Boardman 34
Ann Arbor 32
Los Angeles 32
Hanoi 30
Ho Chi Minh City 29
Redmond 29
Bengaluru 24
Nanjing 24
New York 23
Abeokuta 21
Buffalo 21
Tokyo 20
Westminster 19
Sofia 17
Dong Ket 16
Jacksonville 16
Padova 16
San Diego 16
Rome 15
Jakarta 13
Pune 13
Florence 12
Genoa 12
Helsinki 12
São Paulo 12
Turin 12
Forlì 11
Guangzhou 11
Montreal 11
Amman 10
Berlin 10
Changsha 10
Düsseldorf 10
Falkenstein 10
Frankfurt am Main 10
Shenyang 10
Tianjin 10
Amsterdam 9
Casatenovo 8
Jinan 8
London 8
Munich 8
Ninh Bình 8
Saint Petersburg 8
Shanghai 8
Cesena 7
Dearborn 7
Exeter 7
Hyderabad 7
Mülheim 7
Nanchang 7
Redondo Beach 7
Verona 7
Vienna 7
Zhengzhou 7
Carlsbad 6
Claymont 6
Des Moines 6
Hebei 6
Modena 6
Nuremberg 6
Paris 6
Phoenix 6
Toronto 6
Chicago 5
Glyfáda 5
Hangzhou 5
Lappeenranta 5
Medford 5
Parma 5
Philadelphia 5
San Marzano Di San Giuseppe 5
Stockholm 5
Trieste 5
Wanchai 5
Biên Hòa 4
Brooklyn 4
Totale 3.381
Salva come PNG Salva come JPEG
Nome #
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer 320
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 239
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 239
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro 221
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells 206
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion 196
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 184
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 173
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. 169
(-)-epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line 167
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 167
Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials 163
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells 156
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines 149
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) 147
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement 146
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma 142
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer 141
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity 141
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 135
Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines 129
(-)-Epigallocatechin-3-gallate down regulates estrogen receptor alpha function in MCF-7 breast carcinoma cells 129
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells 125
SOCS-2 expression in MCF-7 and MDA-MB-231 cells 122
Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma. 116
EGCG mediated targeting of deregulated signaling pathways and non-coding rnas in different cancers: Focus on JAK/STAT, Wnt/β-catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL mediated signaling pathways 114
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy 112
Trattamento di cellule MCF-7 resistenti al tamoxifene con (-)-epigallocatechina-3-gallato 112
Proteomic profile of BxPC-3 cells after treatment with BRC4 97
null 91
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. 90
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 85
Green tea in human cancer 78
XXI Convegno Annuale ABCD (Stress cellulare: sopravvivenza ed apoptosi), Atti convegno 75
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in cancer treatment 37
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 26
Totale 5.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 45 11 17 51 30 35 44
2021/2022466 21 16 34 41 27 27 10 47 14 22 101 106
2022/2023729 49 110 23 87 75 55 19 26 98 40 42 105
2023/2024374 61 38 14 42 21 46 41 31 11 16 20 33
2024/20251.028 59 99 79 74 152 55 67 26 35 78 87 217
2025/20261.363 268 271 233 262 238 91 0 0 0 0 0 0
Totale 5.139